Scarica l'app Stockscreener
91.47
0.12%
-0.11
Dopo l'orario di chiusura:
91.47
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LNTH Giù?
Forum
Previsione
Precedente Chiudi:
$91.58
Aprire:
$91.53
Volume 24 ore:
572.47K
Relative Volume:
0.57
Capitalizzazione di mercato:
$6.36B
Reddito:
$1.50B
Utile/perdita netta:
$427.61M
Rapporto P/E:
15.22
EPS:
6.01
Flusso di cassa netto:
$423.98M
1 W Prestazione:
-4.60%
1M Prestazione:
-1.28%
6M Prestazione:
-24.78%
1 anno Prestazione:
+65.50%
Intervallo 1D:
$90.50
$92.80
Intervallo di 1 settimana:
$87.77
$95.81
Portata 52W:
$50.20
$126.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
Nome
Lantheus Holdings Inc
Settore
Telefono
978 671-8001
Indirizzo
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Confronta LNTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
91.47 | 6.36B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
165.89 | 74.84B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
12.92 | 40.96B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.92 | 24.83B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
143.26 | 14.50B | 2.24B | 385.90M | 440.10M | 3.73 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-18 | Iniziato | Goldman | Buy |
| 2024-09-03 | Iniziato | Redburn Atlantic | Buy |
| 2024-07-10 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-12-18 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Iniziato | TD Cowen | Outperform |
| 2023-09-29 | Iniziato | William Blair | Outperform |
| 2023-03-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-11-30 | Iniziato | SVB Leerink | Outperform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-05-09 | Iniziato | B. Riley Securities | Buy |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2021-02-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-29 | Ripresa | Jefferies | Buy |
| 2019-08-16 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-09-23 | Ripresa | Credit Suisse | Neutral |
| 2016-02-24 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-12-11 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Iniziato | Credit Suisse | Outperform |
| 2015-07-20 | Iniziato | Jefferies | Buy |
| 2015-07-20 | Iniziato | RBC Capital Mkts | Outperform |
| 2015-07-20 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-20 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Lantheus Holdings Inc Borsa (LNTH) Ultime notizie
Lantheus director James Thrall sells $94,760 in stock - MSN
Shelton Wealth Management LLC Boosts Stock Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
3,609 Shares in Lantheus Holdings, Inc. (NASDAQ:LNTH) Acquired by Empirical Asset Management LLC - MarketBeat
Insider Selling: Lantheus Holdings, Inc. (NASDAQ:LNTH) Director Sells 1,000 Shares of Stock - MarketBeat
Lantheus Holdings, Inc. (NASDAQ:LNTH) Shares Sold by Burney Co. - MarketBeat
Lantheus director James Thrall sells $94,760 in stock By Investing.com - Investing.com Canada
Insider Sell: James Thrall Sells 1,000 Shares of Lantheus Holdin - GuruFocus.com
Lantheus Holdings, Inc. – Consensus ‘strong_buy’ rating and 44.2% Upside Potential - DirectorsTalk Interviews
Lantheus Holdings Inc (LNTH) Trading Down 3.47% on Jan 16 - GuruFocus.com
How To Trade (LNTH) - Stock Traders Daily
LNTH: LMI Acquisition and NeuraCeq - MSN
Lantheus Holdings' SWOT analysis: radiopharmaceutical leader's stock faces growth hurdles - Investing.com Canada
Lantheus Holdings’ SWOT analysis: radiopharmaceutical leader’s stock faces growth hurdles - Investing.com Nigeria
What 4 Analyst Ratings Have To Say About Lantheus Holdings - Benzinga
Lantheus Holdings, Inc. (LNTH): A Bull Case Theory - Insider Monkey
Lantheus (NASDAQ:LNTH) Receives "Market Outperform" Rating from JMP Securities - MarketBeat
Lantheus to acquire Life Molecular Imaging for up to $750 million, expanding Alzheimer's PET portfolio - DOTmed HealthCare Business News
Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives $131.86 Consensus Price Target from Brokerages - MarketBeat
Lantheus (LNTH) Acquires Life Molecular Imaging for $750MM&A - HIT Consultant
5 Firms Steer Up-To-$750M Sale Of Life Molecular Imaging - Law360
Lantheus Holdings, Inc. (NASDAQ:LNTH) Holdings Boosted by Reinhart Partners LLC. - MarketBeat
Why Lantheus Holdings (LNTH) Stock Is Down 4% - Benzinga
Lantheus to acquire Life Molecular Imaging - The Pharma Letter
Lantheus Acquires Life Molecular Imaging for $350 Million - TipRanks
American giant buying South African-owned company for R14 billion - BusinessTech
Lantheus to acquire PET agent developer Life Molecular Imaging for up to $750M - Radiology Business
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million - citybiz
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer's Disease Radiodiagnostic Market - The Manila Times
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market - GlobeNewswire Inc.
Health Check: Radiopharm dials up after gaining new major shareholder - MSN
Harbor Capital Advisors Inc. Has $13.01 Million Stake in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
Radiopharm gets a new, major shareholder - The Cairns Post
Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement - GlobeNewswire
Radiopharm Secures $5M Investment from Lantheus at Stunning 150% Premium for Cancer Drug Development - StockTitan
Radiopharm Theranostics (ASX:RAD, NASDAQ:RADX) Announces US$5Mn Private Placement with Lantheus Holdings - Kalkine Media
Radiopharm Strengthens Ties with Lantheus Through $5 Million Investment - TipRanks
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices - MSN
Lantheus Holdings (NASDAQ:LNTH) jumps 8.3% this week, though earnings growth is still tracking behind five-year shareholder returns - Simply Wall St
Here’s What Lifted Lantheus Holdings (LNTH) in Q3 - Yahoo Finance
Trend Tracker for (LNTH) - Stock Traders Daily
JPMorgan Chase & Co. Has $62.85 Million Stock Holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
Lantheus Holdings, Inc. – Consensus ‘strong_buy’ rating and 50.6% Upside Potential - DirectorsTalk Interviews
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Inplay Oil Corp (IPO-T) QuotePress Release - The Globe and Mail
Lantheus Holdings: Powerhouse Potential In 2025 - Seeking Alpha
LNTH Makes Notable Cross Below Critical Moving Average - Nasdaq
Radiopharm Theranostics Limited Announces Strategic Co-Development Partnership with Lantheus for Australia - Marketscreener.com
Radiopharm Partners with Lantheus to Advance Oncology Treatments - MSN
(LNTH) Technical Data - Stock Traders Daily
Principal Financial Group Inc. Has $26.19 Million Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
Options Exercise: BRIAN MARKISON At Lantheus Holdings Realizes $2.73M - Benzinga
Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.08%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):